Revelation Biosciences Inc (REVB)
$1.01
$0.01
(1.00%)
As on 03-Sep-2026 16:00EDT
Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
0
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-6.6
-
Face value
--
-
Shares outstanding
3,983,416
10 Years Aggregate
CFO
$91.30 Mln
EBITDA
$-31.55 Mln
Net Profit
$40.34 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Revelation Biosciences Inc (REVB)
| -68.4 | 6.3 | -4.7 | -90.6 | -93.6 | -94.5 | -77.5 |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Revelation Biosciences Inc (REVB)
| -96.4 | -96.8 | -92.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Revelation Biosciences Inc (REVB)
|
1.0 | 4.2 | 0.0 | -10.8 | -- | -113.6 | 0 | 0.4 |
| 86.5 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 271.1 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 74.0 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.1 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.8 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 371.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 542.6 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 593.4 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 355.2 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Revelation Biosciences Inc (REVB)
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform... of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California. Read more
-
CEO & Director
Mr. James M. Rolke
-
CEO & Director
Mr. James M. Rolke
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Revelation Biosciences Inc (REVB)
What is the current share price of Revelation Biosciences Inc (REVB) Today?
The share price of Revelation Biosciences Inc (REVB) is $1.01 (NASDAQ) as of 03-Sep-2026 16:00 EDT. Revelation Biosciences Inc (REVB) has given a return of -93.62% in the last 3 years.
What is the current PB & PE ratio of Revelation Biosciences Inc (REVB)?
The P/E ratio of Revelation Biosciences Inc (REVB) is 0.04 times as on 28-Aug-2026.
The P/B ratio of Revelation Biosciences Inc (REVB) is 0.41 times as on 28-Aug-2026, a 92 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.06 |
0.06 |
2024 |
-0.01 |
0.03 |
2023 |
-0.07 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
-0.31 |
-37.92 |
What is the 52 Week High and Low of Revelation Biosciences Inc (REVB)?
The 52-week high and low of Revelation Biosciences Inc (REVB) are Rs 11.60 and Rs 0.88 as of 04-Sep-2026.
What is the market cap of Revelation Biosciences Inc (REVB)?
Revelation Biosciences Inc (REVB) has a market capitalisation of $ 4 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Revelation Biosciences Inc (REVB)?
Before investing in Revelation Biosciences Inc (REVB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.